![Jason Cavalier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 383 231 $ in data 31/05/2026
Jason Cavalier is currently Chief Financial & Accounting Officer at Lyra Therapeutics, Inc. since 2026.
Formerly, Mr. Cavalier was Director-Mergers & Acquisitions at RBC Capital Markets LLC from 2009 to 2017 and MD, Head-Life Sciences Mergers & Acquisitions at Cantor Fitzgerald & Co. from 2017 to 2021.
Education includes an undergraduate degree from Cornell University and an MBA from Columbia Business School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
LYRA THERAPEUTICS, INC. 29,18% | 01/04/2026 | 517.880 ( 29,18% ) | 383 231 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| LYRA THERAPEUTICS, INC. | Direttore Finanziario/CFO | 13/09/2021 |
| Società | Posizione | Fine |
|---|---|---|
Cantor Fitzgerald & Co.
 Cantor Fitzgerald & Co. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/05/2021 |
RBC Capital Markets LLC
 RBC Capital Markets LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/04/2017 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Cantor Fitzgerald & Co.
Cantor Fitzgerald & Co. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RBC Capital Markets LLC
RBC Capital Markets LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Lyra Therapeutics, Inc.
 Lyra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage therapeutics company which develops and commercializes novel integrated drugs for treatment of patients with ear, nose and throat and ENT diseases | Health Technology |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
